ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000247675.2	Tanespimycin	Breast invasive carcinoma	0.045788838	Resistant
ENSG00000247675.2	Tanespimycin	Chronic Lymphocytic Leukemia	0.021354015	Resistant